New Survey Reveals Insights on Cannabis-Related Health Risks
This article presents a cannabis health risk survey analysis focusing on clinical relevance and patient safety. Without detailed methodology, the survey's findings remain unclear. Clinicians should rely on evidence-based research rather than incomplete…
Insights from the 2024 Cannabis Research Conference
The 2024 cannabis research conference showcases emerging clinical research and evidence-based medicine developments. This event is pivotal for clinicians seeking the latest therapeutic insights. Attendees gain valuable updates to inform patient care…
The Medical Case for Cannabis: 5,000 Years of Medicine Meets Modern Science – Verdi
The medical case cannabis presents spans 5,000 years of medicinal use combined with modern scientific research. This article highlights the evolving evidence-based practice of cannabis medicine. Understanding this medical case cannabis offers supports…
This Overlooked Hormone Could Explain Blood Pressure Challenges
Emerging research on blood pressure hormone regulation highlights a potential factor in persistent hypertension. This overlooked hormone may influence cardiovascular health and treatment outcomes. Understanding its role is crucial for advancing blood…
Major Review Finds Very Little Evidence for Cannabis Treating Anxiety, PTSD, or Psychotic Disorders
A major cannabis efficacy anxiety PTSD review reveals very little evidence supporting cannabis use for anxiety and PTSD. This challenges common clinical assumptions and highlights the need for more rigorous research. Patients and clinicians should…
Medicinal Cannabis Use: Clinical Relevance and Emerging Research
Clinical relevance medicinal cannabis is increasingly important as new research questions its benefits. Clinicians must balance evidence with patient experiences. This article highlights the need for evidence-based counseling in medicinal cannabis use.
Week in Weed – March 28, 2026 – StratCann Insights
This Week in Weed highlights notable clinical interest cannabis developments from March 28, 2026. Emerging findings and policy updates are closely monitored for clinical relevance. Evidence-based insights support informed decision-making in cannabis…
Clinical Implications of Real-World Evidence from the CARE Study [Response to Letter]
Clinical implications real world evidence from the CARE study provide valuable insights into medical cannabis outcomes. This research bridges gaps left by controlled trials by capturing diverse patient experiences. Understanding this evidence helps…
Avicanna Subsidiary Achieves First Commercial Export of CBG Cultivar to Australia
Minor cannabinoids clinical research is advancing with Avicanna's subsidiary completing the first commercial export of a CBG-dominant cultivar to Australia. CBG offers distinct therapeutic potential compared to THC and CBD. This milestone marks growing…
Ibogaine Research Pilot Program One Step Closer to Reality After Committee Vote – Denver7
The ibogaine research pilot program in Colorado marks a significant step toward clinical investigation of this psychedelic. This program focuses on addiction treatment research while addressing cardiac safety concerns. The pilot aims to establish…